Catalyst Pharmaceuticals And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Catalyst Pharmaceuticals (CPRX), STAAR Surgical Company (STAA), AZZ Incorporated (AZZ) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Catalyst Pharmaceuticals (CPRX)

73.5% sales growth and 25.35% return on equity

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Earnings Per Share

As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.71.

PE Ratio

Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 21.66. Meaning, the purchaser of the share is investing $21.66 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.35%.

Sales Growth

Catalyst Pharmaceuticals’s sales growth is 51.6% for the present quarter and 73.5% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 133.3% and 125%, respectively.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 861041 which is 67.3% below its average volume of 2633800.

2. STAAR Surgical Company (STAA)

28.2% sales growth and 12.58% return on equity

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Earnings Per Share

As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.12.

PE Ratio

STAAR Surgical Company has a trailing twelve months price to earnings ratio of 602.17. Meaning, the purchaser of the share is investing $602.17 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.58%.

Volume

Today’s last reported volume for STAAR Surgical Company is 260234 which is 65.93% below its average volume of 763986.

Yearly Top and Bottom Value

STAAR Surgical Company’s stock is valued at $72.26 at 19:22 EST, way under its 52-week high of $112.27 and way above its 52-week low of $46.36.

3. AZZ Incorporated (AZZ)

21.8% sales growth and 13.85% return on equity

AZZ Inc. provides galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, refining, and industrial markets in the United States and internationally. The company operates through two segments, Infrastructure Solutions and Metal Coatings. The Metal Coatings segment offers hot dip galvanizing, powder coating, anodizing, plating, and other metal coating applications to the steel fabrication and other industries. It serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. The Infrastructure Solutions segment provides products and services to support industrial and electrical applications. It offers custom switchgear, electrical enclosures, medium and high voltage bus ducts, explosion proof and hazardous duty lighting, nuclear safety-related equipment, and tubular products, as well as solutions and engineering resources to multi-national companies and small independent companies. This segment sells its products through internal sales force, manufacturers' representatives, distributors, and agents. The company was incorporated in 1956 and is headquartered in Fort Worth, Texas.

Earnings Per Share

As for profitability, AZZ Incorporated has a trailing twelve months EPS of $3.97.

PE Ratio

AZZ Incorporated has a trailing twelve months price to earnings ratio of 10.52. Meaning, the purchaser of the share is investing $10.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.

Volume

Today’s last reported volume for AZZ Incorporated is 90177 which is 29.52% below its average volume of 127952.

Yearly Top and Bottom Value

AZZ Incorporated’s stock is valued at $41.76 at 19:22 EST, way below its 52-week high of $50.84 and way higher than its 52-week low of $30.21.

4. Selective Insurance Group (SIGI)

9.1% sales growth and 9.79% return on equity

Selective Insurance Group, Inc., together with its subsidiaries, provides insurance products and services in the United States. It operates through four segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. The company offers property insurance products, which covers the financial consequences of accidental loss of an insured's real property, personal property, and/or earnings due to the property's loss; and casualty insurance products that covers the financial consequences of employee injuries in the course of employment, and bodily injury and/or property damage to a third party, as well as flood insurance products. It also invests in fixed income investments and commercial mortgage loans, as well as equity securities and alternative investment portfolio. The company offers its insurance products and services to businesses, non-profit organizations, local government agencies, and individuals through independent retail agents and wholesale general agents. Selective Insurance Group, Inc. was founded in 1926 and is headquartered in Branchville, New Jersey.

Earnings Per Share

As for profitability, Selective Insurance Group has a trailing twelve months EPS of $5.61.

PE Ratio

Selective Insurance Group has a trailing twelve months price to earnings ratio of 18.1. Meaning, the purchaser of the share is investing $18.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.79%.

5. Infosys Limited (INFY)

8.9% sales growth and 30.66% return on equity

Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application development and management, independent validation, product engineering and management, infrastructure management, enterprise application management, and support and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Infosys Nia, an artificial intelligence platform; Infosys McCamish – an insurance platform; Wingspan, a customizable learning platform; Stater mortgage servicing platform; Panaya automation suite; and Skava, an e-commerce suite. The company serves clients in the financial services and insurance, life sciences and healthcare, manufacturing, retail, consumer packaged goods and logistics, hi-tech, communications, telecom OEM, media, energy, utilities, resources, services, and other industries. It has collaboration agreements with Rolls-Royce, BP plc, Newmont Corporation, RXR Realty, Majesco Limited, and Centre for Accessibility Australia; and a strategic partnership with The Economist Group Limited to enable and enhance sustainability solutions through a business-to-business model. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.

Earnings Per Share

As for profitability, Infosys Limited has a trailing twelve months EPS of $0.61.

PE Ratio

Infosys Limited has a trailing twelve months price to earnings ratio of 31.53. Meaning, the purchaser of the share is investing $31.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.66%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 5.6% and 5.6%, respectively.

Moving Average

Infosys Limited’s value is above its 50-day moving average of $18.79 and higher than its 200-day moving average of $18.82.

6. ESCO Technologies (ESE)

8.7% sales growth and 7.96% return on equity

ESCO Technologies Inc. produces and supplies engineered products and systems for industrial and commercial markets worldwide. It operates through Aerospace & Defense, Utility Solutions Group, and RF Shielding and Test segments. The Aerospace & Defense segment designs and manufactures filtration products, including hydraulic filter elements and fluid control devices used in commercial aerospace applications; filter mechanisms used in micro-propulsion devices for satellites; and custom designed filters for manned aircraft and submarines. It also designs, develops, and manufactures elastomeric-based signature reduction solutions for U.S. naval vessels; and mission-critical bushings, pins, sleeves, and precision-tolerance machined components for landing gear, rotor heads, engine mounts, flight controls, and actuation systems for the aerospace and defense industries. The Utility Solutions Group segment provides diagnostic testing solutions that enable electric power grid operators to assess the integrity of high-voltage power delivery equipment; and decision support tools for the renewable energy industry, primarily wind and solar. The RF Shielding and Test segment designs and manufactures RF test and secure communication facilities, acoustic test enclosures, RF and magnetically shielded rooms, RF measurement systems, and broadcast and recording studios; and RF absorptive materials and filters, active compensation systems, antennas, antenna masts, turntables, electric and magnetic probes, RF test cells, proprietary measurement software, and other test accessories to perform various tests. It also provides services, such as calibration for antennas and field probes, chamber certification, field surveys, customer training, and various product tests. The company distributes its products through a network of distributors, sales representatives, direct sales teams, and in-house sales personnel. The company was incorporated in 1990 and is based in St. Louis, Missouri.

Earnings Per Share

As for profitability, ESCO Technologies has a trailing twelve months EPS of $3.16.

PE Ratio

ESCO Technologies has a trailing twelve months price to earnings ratio of 29.64. Meaning, the purchaser of the share is investing $29.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.96%.

Volume

Today’s last reported volume for ESCO Technologies is 38573 which is 55.46% below its average volume of 86608.

Yearly Top and Bottom Value

ESCO Technologies’s stock is valued at $93.66 at 19:22 EST, below its 52-week high of $96.69 and way above its 52-week low of $60.03.

Revenue Growth

Year-on-year quarterly revenue growth grew by 24.8%, now sitting on 857.5M for the twelve trailing months.

7. Advanced Energy Industries (AEIS)

8% sales growth and 21.43% return on equity

Advanced Energy Industries, Inc. designs, manufactures, sells, and supports precision power conversion, measurement, and control solutions worldwide. It offers plasma power solutions, including direct current (DC), pulsed DC, low frequency alternating current, high voltage, and radio frequency (RF) power supplies, as well as RF power supplies, RF matching networks, and RF instrumentation products; and remote plasma sources for reactive gas applications. The company also provides power control modules and thermal instrumentation products for rapid thermal processing, chemical vapor deposition, epitaxy, crystal growing, and chemical processing, as well as metal, carbon fiber, and glass manufacturing and other industrial power applications; high voltage DC-DC products for semiconductor wafer processing and metrology, electrostatic clamping of substrates, scientific instrumentation, mass spectrometry, and X-ray systems for industrial and analytical applications; and low voltage DC-DC board mounted solutions for use in healthcare, telecommunications, test and measurement, instrumentation, and industrial equipment applications, as well as distributed power in server and storage systems. In addition, it offers gas sensing and monitoring products for the energy market, air quality monitoring, and automobile emission monitoring and testing; and embedded power products for medical equipment or IEC 60950-1 for information technology equipment. Further, it offers conversions, upgrades, and refurbishments and used equipment to companies, as well as repair services. The company provides its products through a direct sales force, independent sales representatives, channel partners, and distributors. Advanced Energy Industries, Inc. was incorporated in 1981 and is headquartered in Denver, Colorado.

Earnings Per Share

As for profitability, Advanced Energy Industries has a trailing twelve months EPS of $5.5.

PE Ratio

Advanced Energy Industries has a trailing twelve months price to earnings ratio of 18.03. Meaning, the purchaser of the share is investing $18.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.43%.

Volume

Today’s last reported volume for Advanced Energy Industries is 210642 which is 19.65% above its average volume of 176035.

8. Hudson Technologies (HDSN)

6.4% sales growth and 88.33% return on equity

Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service for facility's refrigeration systems and other energy systems applications; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was incorporated in 1991 and is headquartered in Woodcliff Lake, New Jersey.

Earnings Per Share

As for profitability, Hudson Technologies has a trailing twelve months EPS of $2.27.

PE Ratio

Hudson Technologies has a trailing twelve months price to earnings ratio of 4.81. Meaning, the purchaser of the share is investing $4.81 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 88.33%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 47.6%, now sitting on 315.56M for the twelve trailing months.

Volume

Today’s last reported volume for Hudson Technologies is 474444 which is 16.41% below its average volume of 567608.

Leave a Reply

Your email address will not be published. Required fields are marked *